Form 8-K - Current report:
SEC Accession No. 0001599901-25-000196
Filing Date
2025-10-14
Accepted
2025-10-14 09:30:16
Documents
13
Period of Report
2025-10-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rna-20251013.htm   iXBRL 8-K 29062
  Complete submission text file 0001599901-25-000196.txt   176726

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20251013.xsd EX-101.SCH 2065
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rna-20251013_def.xml EX-101.DEF 7270
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rna-20251013_lab.xml EX-101.LAB 27042
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rna-20251013_pre.xml EX-101.PRE 19081
16 EXTRACTED XBRL INSTANCE DOCUMENT rna-20251013_htm.xml XML 2991
Mailing Address 3020 CALLAN ROAD SAN DIEGO CA 92121
Business Address 3020 CALLAN ROAD SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 251390062
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)